JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • School of Public Health
    • Department of Epidemiology
    • SPH Epidemiology Papers
    • View Item
    •   OpenBU
    • School of Public Health
    • Department of Epidemiology
    • SPH Epidemiology Papers
    • View Item

    Prognosis of Ovarian Cancer Subsequent to Venous Thromboembolism: A Nationwide Danish Cohort Study

    Thumbnail
    Download/View
    1471-2407-6-189.pdf (272.0Kb)
    License
    Copyright 2006 Tetsche et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    Date Issued
    2006-7-17
    Related DOI
    10.1186/1471-2407-6-189
    Author
    Tetsche, Mette S.
    Nørgaard, Mette
    Pedersen, Lars
    Lash, Timothy L.
    Sørensen, Henrik T.
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/3254
    Citation
    Tetsche, Mette S, Mette Nørgaard, Lars Pedersen, Timothy L Lash, Henrik T Sørensen. "Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study" BMC Cancer 6:189. (2006)
    Abstract
    BACKGROUND. Venous thromboembolism (VTE) is associated with ovarian cancer and may impact the prognosis of ovarian cancer. Our aims were to examine the extent of disease at the time of the diagnosis of ovarian cancer and to estimate the impact of VTE on survival of ovarian cancer. METHODS. We identified 12,835 ovarian cancer patients diagnosed from 1980 to 2003 in the Danish Cancer Registry and obtained information on previous primary VTE diagnosis from the Danish National Hospital Discharge Registry. Ovarian cancer patients with previous VTE related to other cancers, surgery, or pregnancy were excluded. The vital status was determined by linking data to the Civil Registration System. RESULTS. We identified 50 ovarian cancer patients diagnosed less than 4 months after the VTE and 78 ovarian cancer patients diagnosed more than 4 months after the VTE diagnosis. Advanced stages tended to be more common among patients with VTE. One-year survivals were 44% and 54% among the two VTE groups, compared with 63% among patients without VTE. Adjusted (for age, calendar time, comorbidity, and FIGO-stage) mortality ratios were 1.7 (95% CI = 1.2–2.5) and 1.2 (95% CI = 0.8–1.7), respectively. CONCLUSION. Ovarian cancer diagnosed less than four months before VTE is associated with an advanced stage and a poorer prognosis.
    Rights
    Copyright 2006 Tetsche et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    Collections
    • SPH Epidemiology Papers [104]

    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Contact Us | Send Feedback | Help